Actively Recruiting
Real-world Study on the Effectiveness and Safety of Control-IQ Technology in Teenagers With Type 1 Diabetes Engaging in Regular Physical Activity
Led by Bruno Bombaci · Updated on 2025-06-25
50
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
B
Bruno Bombaci
Lead Sponsor
U
University of Messina
Collaborating Sponsor
AI-Summary
What this Trial Is About
We hypothesize that the use of the Control-IQ system positively influences glycemic control in teenagers with type 1 diabetes during physical activity. To test this hypothesis, we will evaluate the glucose profiles (based on CGM metrics) of adolescents engaging in different types, intensities, and durations of physical activity over a 14-day period, in real-life conditions. We will compare glucose control on exercise days with that on sedentary days. As a secondary objective, we will investigate the influence of factors such as anthropometric characteristics, type and duration of exercise, the use of the exercise mode and other management strategies used for physical activity, on glycemic outcomes. Regarding the safety, we will report any episodes of severe hypoglycemia or diabetic ketoacidosis (DKA). This is an observational, open-label, non-randomized, real-world study. Each participant will be provided with a diary to record detailed information about physical activity sessions over a 14-day period, including type, intensity, and duration of exercise, and timing and composition of pre-exercise meals. Clear instructions on how to complete the diary will be provided. CGM metrics will be analyzed throughout the 14-day observation period, including time in range, time in tight range, time above range, time below range, mean glucose level, and coefficient of variation. A daily comparison will be performed between metrics recorded on days of physical activity and sedentary days, assessing the entire day as well as daytime (07:00-23:00) and nighttime (23:00-07:00) periods. The influence of factors such as anthropometrics, type of physical activity, the use of the exercise mode and other specific management strategies, type and duration of exercise, and pre-exercise meals on CGM metrics will be evaluated. The frequency of severe hypoglycemia and DKA episodes, as defined by international guidelines, will be assessed.
CONDITIONS
Official Title
Real-world Study on the Effectiveness and Safety of Control-IQ Technology in Teenagers With Type 1 Diabetes Engaging in Regular Physical Activity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of type 1 diabetes according to International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines
- Duration of diabetes greater than 12 months
- Age less than 20 years
- Completed pubertal development according to Tanner stage
- Use of Control-IQ technology for at least 3 months
- Automatic mode use for at least 70% of the time during the 2 weeks before enrollment
- Continuous glucose monitoring use for at least 70% of the time during the 2 weeks before enrollment
- Regular physical activity with at least 2 sessions per week, each lasting at least 45 minutes
You will not qualify if you...
- Uncontrolled celiac disease or thyroid disease
- Presence of other chronic illnesses
- Psychiatric or neurological conditions, including eating disorders, that may interfere with the study
- Chronic use of medications (other than insulin) that may affect glucose control
- Chronic use of substances or drugs that could impact continuous glucose monitoring accuracy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital of Messina
Messina, Italy, Italy, 98125
Actively Recruiting
Research Team
B
Bruno Bombaci, MD
CONTACT
G
Giuseppina Salzano, PhD MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here